In this video roundtable discussion, Carol Wysham, MD, interviews Eugene E. Wright, Jr., MD, and Hope Warshaw, MMSc, RD, CDCES, BC-ADM, about the multidisciplinary approach to managing people with...
In this podcast, Charlotte M. Rolle, MD, MPH, discusses her team's research that evaluated the efficacy and safety of switching HIV treatment using
bictegravir/emtricitabine/tenofovir alafenamide to...
In this video, Maura Marcucci, MD, MSc, discusses her study's surprising results, which showed no differences between hypotension-avoidance and hypertension-avoidance strategies for decreasing adverse...
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
In this video, cardiologists Seth Martin, MD, MHS, and Jessica Golbus, MD, speak with Sarah Riley, MSN, CRNP, CHFN, and Michael Dorsch, PharmD, MS, in a roundtable discussion on the role of a...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
